Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Accumulated Expenses (2016 - 2025)

INVO Fertility (IVF) has disclosed Accumulated Expenses for 15 consecutive years, with $342957.0 as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses fell 46.42% to $342957.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $342957.0, a 46.42% decrease, with the full-year FY2024 number at $713483.0, down 1.21% from a year prior.
  • Accumulated Expenses was $342957.0 for Q3 2025 at INVO Fertility, down from $365694.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.9 million in Q1 2025 to a low of $342957.0 in Q3 2025.
  • A 5-year average of $720068.3 and a median of $641823.0 in 2022 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 211.5% in 2023, then tumbled 46.42% in 2025.
  • INVO Fertility's Accumulated Expenses stood at $581689.0 in 2021, then skyrocketed by 62.67% to $946262.0 in 2022, then decreased by 23.67% to $722251.0 in 2023, then fell by 1.21% to $713483.0 in 2024, then tumbled by 51.93% to $342957.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Accumulated Expenses are $342957.0 (Q3 2025), $365694.0 (Q2 2025), and $1.9 million (Q1 2025).